Filing Details

Accession Number:
0001209191-22-002604
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-07 20:26:07
Reporting Period:
2021-12-29
Accepted Time:
2022-01-07 20:26:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1610618 Cidara Therapeutics Inc. CDTX Biological Products, (No Disgnostic Substances) (2836) 461537286
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1639144 Paul Daruwala 6310 Nancy Ridge Drive
Suite 101
San Diego CA 92121
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-29 9,900 $0.00 192,431 No 4 M Direct
Common Stock Disposition 2022-01-05 5,133 $1.25 187,298 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2021-12-29 5,000 $0.00 5,000 $0.00
Common Stock Restricted Stock Unit Disposition 2021-12-29 4,900 $0.00 4,900 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,500 2027-09-17 No 4 M Direct
5,600 2029-01-30 No 4 M Direct
Footnotes
  1. The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021.
  2. Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on December 29, 2021 and January 1, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
  3. Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
  4. On September 18, 2017, the Reporting Person was granted restricted stock units totaling 25,000 shares subject to vesting upon the achievement of various milestones.
  5. On January 31, 2019, the Reporting Person was granted restricted stock units totaling 14,000 shares subject to vesting upon the achievement of various milestones.